XOMA Royalty (XOMA) Cash & Current Investments (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Cash & Current Investments came in at $86.1 million in Q1 2026, up 1088.9% year-on-year from $7.2 million in Q1 2025, and down 2.55% quarter-over-quarter from $88.3 million in Q4 2025.

XOMA Royalty (XOMA) Cash & Current Investments (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Cash & Current Investments across 17 years of filings, most recently posting $86.1 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $86.1 million, up 1088.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.1 million (up 1088.9% YoY), and the FY2025 annual result was $88.3 million, up 756.68% from the prior year.
  • Cash & Current Investments came in at $86.1 million for Q1 2026 at XOMA Royalty, down from $88.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $153.4 million in Q4 2023 to a low of $4.8 million in Q3 2024.
  • The 5-year median for Cash & Current Investments is $44.6 million (2023), against an average of $61.5 million.
  • Across the five-year window, Cash & Current Investments plunged 94.69% in 2025 and surged 1088.9% in 2026, its largest moves.
  • XOMA Royalty's Cash & Current Investments stood at $30.6 million in 2022, then jumped by 400.9% to $153.4 million in 2023, then sank by 93.28% to $10.3 million in 2024, then jumped by 756.68% to $88.3 million in 2025, then retreated by 2.55% to $86.1 million in 2026.
  • The last three Cash & Current Investments figures came in at $86.1 million (Q1 2026), $88.3 million (Q4 2025), and $55.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 32.30 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 2.13 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 2.77 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 18.44 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 XOMA Royalty 5.48 Mn -60.60 Mn - 86.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.10 Mn
Dec 31, 2025 88.35 Mn
Sep 30, 2025 55.47 Mn
Jun 30, 2025 15.79 Mn
Mar 31, 2025 7.24 Mn
Dec 31, 2024 10.31 Mn
Sep 30, 2024 4.80 Mn
Jun 30, 2024 144.60 Mn
Mar 31, 2024 136.43 Mn
Dec 31, 2023 153.45 Mn
Sep 30, 2023 33.69 Mn
Jun 30, 2023 31.72 Mn
Mar 31, 2023 44.61 Mn
Dec 31, 2022 30.64 Mn
Sep 30, 2022 30.64 Mn
Jun 30, 2022 83.71 Mn
Mar 31, 2022 88.60 Mn
Dec 31, 2021 94.10 Mn
Sep 30, 2021 72.17 Mn
Jun 30, 2021 81.26 Mn